Literature DB >> 25374030

An oligodeoxynucleotide with CCT repeats restrains CpG ODN-induced TLR9 trafficking.

Xiaoling Zhang, Wei Sun, Xiuli Wu, Hua Wang, Youyou Yan, Sheng Guo, Dandan Song, Hainan Li, Shuang Gao, Luowei Wang, Yongli Yu, Liying Wang1.   

Abstract

Toll-like receptor 9 (TLR9) can sense pathogen DNA and CpG ODN or even self-DNA by trafficking assisted by Unc93B1, an endoplasmic reticulum (ER) transmembrane protein, from ER to endolysosomes or cell surface. In previous study, we found that an oligodeoxynucleotide with CCT repeats (SAT05f) could selectively inhibit TLR7/9 activation. However, the mechanism for the inhibitory activity of SAT05f is still unknown. In present research, it was found that SAT05f could inhibit CpG ODN-induced the intracellular trafficking of TLR9 and Unc93B1 with feedback the responses of decreased surface TLR9 and enhanced TLR9 mRNA expression but not influence TLR9 protein level by using human plasmacytoid dendritic cell line CAL-1 cells, suggesting that SAT05f inhibits TLR9 activation by restraining TLR9 trafficking. Since the mitochondrial DNA released from injured tissue can cause systemic inflammatory response syndrome (SIRS), this study may provide valuable data for prevention and treatment of SIRS and rescue severe trauma patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25374030     DOI: 10.2174/1389201015666141031114708

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  2 in total

1.  Synergistic Stimulation with Different TLR7 Ligands Modulates Gene Expression Patterns in the Human Plasmacytoid Dendritic Cell Line CAL-1.

Authors:  Tobias Hilbert; Folkert Steinhagen; Christina Weisheit; Georg Baumgarten; Andreas Hoeft; Sven Klaschik
Journal:  Mediators Inflamm       Date:  2015-12-06       Impact factor: 4.711

2.  The Effect of Photothermal Therapy on Osteosarcoma With Polyacrylic Acid-Coated Gold Nanorods.

Authors:  Su Pan; Hongcun Xing; Xuqi Fu; Hongmei Yu; Zhaogang Yang; Yudan Yang; Wei Sun
Journal:  Dose Response       Date:  2018-08-29       Impact factor: 2.658

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.